Table 2a.
ß | 95% CI | p-value | ||
---|---|---|---|---|
Total sample | ||||
Model with no interaction term | PGS | −4 | −33 ~ 25 | 0.79 |
Model with 2-way interaction term | PGS*intervention | −31 | −88 ~ 26 | 0.28 |
Model with 3-way interaction term | PGS*intervention*year1 | −22 | −107 ~ 64 | 0.62 |
PGS*intervention*year4 | −13 | −103 ~ 77 | 0.77 | |
| ||||
Effect modification: age | ||||
Model with 2-way interaction term | PGS*age | 4 | 0 ~ 8 | 0.05 |
Model with 3-way interaction term | PGS*intervention*age | −4 | −12 ~ 5 | 0.39 |
Model with 4-way interaction term | PGS*intervention*year1*age | 11 | −1 ~ 24 | 0.08 |
PGS*intervention*year4*age | −2 | −14 ~ 12 | 0.81 |
PGS, polygenic score; 1 unit increase in PGS roughly equates to one additional effect allele for higher physical activity. All models were controlled for age, sex, baseline body mass index, principal component 1 and principal component 2, and study sites as well as all subcomponents of the interaction terms (e.g., PGS*age included PGS and age separately).